Medical Xpress
APRIL 13, 2025
Exercise therapy is suggested as a first-line treatment to improve joint pain and loss of function caused by osteoarthritis (OA), a musculoskeletal disorder that affects more than 595 million people worldwide. Yoga and strengthening exercises are both known to be effective ways of managing knee OA, but is one better than the other?
FDA Law Blog
APRIL 13, 2025
By Sarah Wicks & Dara Katcher Levy FDAs Office of Prescription Drug Promotion (OPDP) issued its second Untitled Letter of 2025 to Taiho Oncology (Taiho) for a healthcare provider branded website for its drug LYTGOBI (futibatinib). This letter, dated March 21, 2025, cites Taihos false or misleading representations about the benefits of the drug, which is considered misbranding under the Federal Food, Drug, and Cosmetic Act.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
JAMA Internal Medicine
APRIL 13, 2025
This risk model projects how many future cancers in the United States could result from annual computed tomography examinations.
Medical Xpress
APRIL 13, 2025
World Health Organization members on Saturday reached agreement over how to tackle future pandemics after three years of discussions, the co-chair of the negotiating body told AFP.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
JAMA Internal Medicine
APRIL 13, 2025
In this issue of JAMA Internal Medicine, Smith-Bindman et al report on the projected number of cancers expected to result from exposure to ionizing radiation during computed tomography (CT) scans performed in the United States in 2023. They estimated that approximately 93 million scans were performed in approximately 62 million patients, which could eventually result in 103000 new cancers.
Medical Xpress
APRIL 13, 2025
A cruel consequence of advanced cancer is the profound apathy many patients experience as they lose interest in once-cherished activities. This symptom is part of a syndrome called cachexia, which affects about 80% of late-stage cancer patients, leading to severe muscle wasting and weight loss that leave patients bone thin despite adequate nutrition.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharma Marketing Network
APRIL 13, 2025
Can pharma brands remain relevant in a digital-first healthcare economy? As the industry pivots toward patient empowerment, AI-enabled solutions, and content-driven search, the real challenge isnt visibilityits authority. Much like the shift from blockbuster drugs to targeted therapies, digital transformation demands new approaches. In this article, well unpack the most effective SEO marketing strategies that align with pharma brands and the 2025 shifting strategyhelping you drive organic traffi
JAMA Internal Medicine
APRIL 13, 2025
This Viewpoint discusses clinicians as legal petitioners of extreme risk protection orders to promote the safety and well-being of patients and communities.
Expert insights. Personalized for you.
128 
Let's personalize your content